The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study
Open accessAbstract
Objectives To determine any long-term effects, 6 and 8 years after childhood enrollment, of the randomly assigned 14-month treatments in the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA; N = 436); to test whether attention-deficit/hyperactivity disorder (ADHD) symptom trajectory through 3 years predicts outcome in subsequent years; and to examine functioning level of the MTA adolescents relative to their non-ADHD peers (local normative comparison group; N = 261).Method Mixed-effects regression models with planned contrasts at 6 and 8 years tested a wide range of symptom and impairment variables assessed by parent, teacher, and youth report.Results In nearly every analysis, the originally randomized treatment groups did not differ significantly on repeated measures or newly analyzed variables (e.g., grades earned in school, arrests, psychiatric hospitalizations, other clinically relevant outcomes). Medication use decreased by 62% after the 14-month controlled trial, but adjusting for this did not change the results. ADHD symptom trajectory in the first 3 years predicted 55% of the outcomes. The MTA participants fared worse than the local normative comparison group on 91% of the variables tested.Conclusions Type or intensity of 14 months of treatment for ADHD in childhood (at age 7.0-9.9 years) does not predict functioning 6 to 8 years later. Rather, early ADHD symptom trajectory regardless of treatment type is prognostic. This finding implies that children with behavioral and sociodemographic advantage, with the best response to any treatment, will have the best long-term prognosis. As a group, however, despite initial symptom improvement during treatment that is largely maintained after treatment, children with combined-type ADHD exhibit significant impairment in adolescence. Innovative treatment approaches targeting specific areas of adolescent impairment are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Long-term follow-up studies suggest that hyperactive and impulsive behaviors tend to decrease with age, while inattentive symptoms show greater persistence and may stay life-long (Biederman et al., 2000; Molina et al., 2009).”
From A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD) (2019) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“potential longer-term efficacy could be the real advantage of tDCS over stimulant medication where effects are discontinued with discontinued drug administration and where effects appear to even wane in long-term continuous administration (Molina et al., 2009), presumably due to brain adaptation to the drug (Fusar-Poli et al., 2012).”
From Cognitive Neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) and Its Clinical Translation (2018) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such delayed consolidation effects reinforce the notion that brain self-regulation via NF affects neuroplasticity and may hence have unique longer-term efficacy compared to stimulant medication which does not affect neuroplasticity and may even loose efficacy over time (Molina et al., 2009), due to potential brain adaptation (Fusar-Poli et al., 2012).”
From Cognitive Neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) and Its Clinical Translation (2018) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As in the 2 previous guidelines, this recommendation is based on the evidence that for many individuals, ADHD causes symptoms and dysfunction over long periods of time, even into adulthood.”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite this large difference in medication use, there were no appreciable between-group differences in long-term academic achievement in reading or mathematics (Molina et al., 2009).”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is the first study of its kind, and results are consistent with other randomized evidence with less controlled designs (Molina et al., 2009; Tamm et al., 2017) in failing to support the expectation that taking stimulant medication during childhood will impact children with ADHD’s long-term academic achievement.”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have identified childhood risk factors associated with a more persistent course, including higher levels of symptoms, comorbid oppositional-defiant disorder (ODD), lower IQ, and family socioeconomic disadvantage.”
From Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood (2016) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As individuals with ADHD enter adolescence, their overt hyperactive and impulsive symptoms tend to decline, whereas their inattentive symptoms tend to persist.13,14”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“ADHD is a chronic condition; therefore, the PCC should manage children and adolescents with ADHD in the same manner that they would children and youth with special health care needs, following the principles of the chronic care model and the medical home (Table 5).”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Authors of longitudinal studies have found that ADHD treatments are frequently not maintained over time13 and impairments persist into adulthood.70”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“We are aware of only two such studies (Molina et al., 2009; Tamm et al., 2017).”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
In the citing paper
“data suggest limited longer-term benefits of stimulant and behavioral interventions, even when applied intensively for both school-age and preschool children (Molina et al., 2009; Riddle et al., 2013).”
From Improving Outcomes for Youth with ADHD: A Conceptual Framework for Combined Neurocognitive and Skill-Based Treatment Approaches (2014) · cites this paper as Molina et al., 2009
In the citing paper
“This suggests that the relative benefits of childhood treatment with stimulant medication, compared with non-pharmacological treatmentsFimprovement in cognitive deficits as well as reductions in symptom severityFmay dissipate after a 2-to 3-year period, whether or not the medication component of treatment is continued or withdrawn (Molina et al, 2009;Swanson et al, 2008a, b).”
From Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (2011) · cites this paper as Molina et al, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,374
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,635
SHAFFER, D., FISHER, P., LUCAS, C. P., DULCAN, M. K., & SCHWAB-STONE, M. E. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200001000-00014 · Cited by 3,505
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Roberts, B. W., & DelVecchio, W. F. (2000) · Psychological Bulletin · doi:10.1037/0033-2909.126.1.3 · Cited by 3,241
Mendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,592
Flagged first, then by citations
2 of the 55 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,000
O’Hara, V. M., Curran, J. L., & Browne, N. T. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00410-0 · Cited by 31
What Have We Learned about Trial Design From NIMH-Funded Pragmatic Trials?
March, J. S., KRAEMER, H. C., Trivedi, M. H., Csernansky, J. G., Davis, J. M., Ketter, T. A., & Glick, I. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.115 · Cited by 29
Gao, Q., Qian, Y., He, X., Sun, L., Chang, W.-L., Li, Y., Cao, Q., Wang, Y., & Qian, Q. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.11.025 · Cited by 31
Eddy, L. D., Dvorsky, M. R., Molitor, S. J., Bourchtein, E., Smith, Z. R., Oddo, L. E., Eadeh, H., & Langberg, J. M. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715616184 · Cited by 27
Attention deficit hyperactivity disorder (ADHD): review for primary care clinicians
Ougrin, D., Chatterton, S., & Banarsee, R. (2010) · London Journal of Primary Care · doi:10.1080/17571472.2010.11493296 · Cited by 29
ADHD in children and adolescents.
Keen, D. V., & Hadijikoumi, I. (2008) · Europe PMC (PubMed Central) · Cited by 29
Do Stimulant Medications Improve Educational and Behavioral Outcomes for Children with ADHD?
Currie, J., Stabile, M., & Jones, L. E. (2013) · National Bureau of Economic Research · doi:10.3386/w19105 · Cited by 29
Medication: The smart-pill oversell
Sharpe, K. (2014) · Nature · doi:10.1038/506146a · Cited by 28
Justice, L. M., Logan, J. A. R., Jiang, H., & Schmitt, M. B. (2016) · American Journal of Speech-Language Pathology · doi:10.1044/2016_ajslp-15-0058 · Cited by 33
Bikic, A., Leckman, J. F., Lindschou, J., Christensen, T. Ø., & Dalsgaard, S. (2015) · Trials · doi:10.1186/s13063-015-0975-8 · Cited by 33
Döpfner, M., von Wirth, E., Metternich-Kaizman, T. W., Schürmann, S., Rademacher, C., & Breuer, D. (2014) · Child Psychiatry & Human Development · doi:10.1007/s10578-014-0452-8 · Cited by 28
Sasaki, T. G., Hashimoto, K., Tachibana, M., Kurata, T., Okawada, K., Ishikawa, M., Kimura, H., Komatsu, H., Ishikawa, M., Hasegawa, T., et al. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s58480 · Cited by 28
Arble, E. P., Kuentzel, J. G., & Barnett, D. (2014) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acu006 · Cited by 28
Qian, Y., Chen, M., Shuai, L., Cao, Q., Yang, L., & Wang, Y. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.208236 · Cited by 32
Duration of effect of oral long-acting stimulant medications for ADHD throughout the day
Brams, M., Moon, E., Pucci, M., & López, F. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.488553 · Cited by 30
Giordani, B., Novak, B., Sikorskii, A. E., Bangirana, P., Nakasujja, N., Winn, B. M., & Boivin, M. J. (2015) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2015.5 · Cited by 27
Long-term medication for ADHD and development of cognitive functions in children and adolescents
Johnson, M., Johnels, J. Å., Östlund, S., Cedergren, K., Omanovic, Z., Hjalmarsson, K., Jakobsson, K., Högstedt, J., & Billstedt, E. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.07.055 · Cited by 27
Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries
Flisher, A. J., Sorsdahl, K. R., Hatherill, S., & Chehil, S. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000235 · Cited by 27
Implications of Changes for the Field
Sibley, M. H., Waxmonsky, J. G., Robb, J. A., & Pelham, W. E. (2012) · Journal of Learning Disabilities · doi:10.1177/0022219412464350 · Cited by 30
Thorsen, A. L., Meza, J. I., Hinshaw, S. P., & Lundervold, A. J. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.02154 · Cited by 29
Self-citationStigmatization and self-perception of youth with attention deficit/hyperactivity disorder
Bussing, R., & Mehta, A. S. (2013) · Patient Intelligence · doi:10.2147/pi.s18811 · Cited by 30
Li, J. J., & Lee, S. S. (2013) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2012.736355 · Cited by 30
Johnstone, J. M., Leung, B. M. Y., Gracious, B., Perez, L. F., Tost, G., Savoy, A., Hatsu, I. E., Hughes, A., Bruton, A. M., & Arnold, L. E. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100478 · Cited by 26
Self-citationHoward, A. L., Kennedy, T. M., Mitchell, J. T., Sibley, M. H., Hinshaw, S. P., Arnold, L. E., Roy, A., Stehli, A., Swanson, J. M., & Molina, B. S. G. (2019) · Psychology of Addictive Behaviors · doi:10.1037/adb0000542 · Cited by 29
Self-citationRosenau, P. T., Openneer, T. J. C., Matthijssen, A. M., van de Loo-Neus, G. H. H., Buitelaar, J. K., van den Hoofdakker, B. J., Hoekstra, P. J., & Dietrich, A. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13419 · Cited by 26
Haack, L. M., & Gerdes, A. C. (2011) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-011-0098-z · Cited by 26
Methylphenidate in Children With ADHD With or Without Learning Disability
Williamson, D., Murray, D. W., Damaraju, C. V., Ascher, S., & Starr, H. L. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712443411 · Cited by 28
Predictors of Polypharmacy and Off-Label Prescribing of Psychotropic Medications
Kearns, M. A., & Hawley, K. M. (2014) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000456592.20622.45 · Cited by 27
Attention‐Deficit/Hyperactivity Disorder in Children and Adolescents
Villodas, M. T., Hinshaw, S. P., & Pfiffner, L. J. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt33 · Cited by 27
Self-citationTaylor, L. E., & Antshel, K. M. (2019) · Journal of Attention Disorders · doi:10.1177/1087054718821734 · Cited by 28
Criaud, M., Wulff, M., Alegría, A. A., Barker, G. J., Giampietro, V., & Rubia, K. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102311 · Cited by 26
Neural and Behavioral Endophenotypes in ADHD
del Campo, N., Müller, U., & Sahakian, B. J. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_200 · Cited by 26
The Comorbidity of ADHD and Bipolar Disorder: Any Less Confusion?
Pataki, C. S., & Carlson, G. A. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0372-5 · Cited by 28
Attention-deficit hyperactivity disorder, drug companies and the internet
Mitchell, J., & Read, J. (2012) · Clinical Child Psychology and Psychiatry · doi:10.1177/1359104510396432 · Cited by 24
KIP3: Robotic Companion as an External Cue to Students with ADHD
Zuckerman, O., Hoffman, G., Kopelman-Rubin, D., Klomek, A., Shitrit, N., Amsalem, Y., & Shlomi, Y. (2016) · International Conference on Tangible, Embedded, and Embodied Interaction · doi:10.1145/2839462.2856535 · Cited by 61
Ghosh, M., Fisher, C. M., Preen, D. B., & Holman, C. D. J. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1399-1 · Cited by 29
Zendarski, N. J., Mensah, F. K., Hiscock, H., & Sciberras, E. (2019) · Journal of Attention Disorders · doi:10.1177/1087054719833167 · Cited by 25
Personalized Medicine in ADHD and Depression: Use of Pharmaco-EEG
Arns, M., & Olbrich, S. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_295 · Cited by 25
Sibley, M. H., Graziano, P. A., Bickman, L., Coxe, S. J., Martin, P., Rodriguez, L. M., Fallah, N., & Ortiz, M. (2020) · Prevention Science · doi:10.1007/s11121-020-01105-7 · Cited by 28
Stein, B. D., Klein, G., Greenhouse, J. B., & Kogan, J. N. (2012) · Psychiatric Services · doi:10.1176/appi.ps.201000532 · Cited by 25
Pelsser, L., Frankena, K., Toorman, J., & Rodrigues Pereira, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00096 · Cited by 25
Voetterl, H., van Wingen, G., Michelini, G., Griffiths, K. R., Gordon, E., DeBeus, R., Korgaonkar, M. S., Loo, S. K., Palmer, D., Breteler, R., et al. (2023) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.02.007 · Cited by 35
Self-citationAzami, S., Moghaddas, A., Sohrābi, F., Nazifi, M., Mirmohammad, M. S., Hemmati, F., Ahmadi, A., Hamzeh‐poor, P., Khari, S., & Lakes, K. D. (2016) · Child and Adolescent Mental Health · doi:10.1111/camh.12157 · Cited by 24
Hazell, P. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32834742db · Cited by 24
Childhood Attention-Deficit/Hyperactivity Disorder and Homelessness: A 33-Year Follow-Up Study
Murillo, L. G., Ramos-Olazagasti, M. A., Mannuzza, S., Castellanos, F. X., & Klein, R. G. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.07.772 · Cited by 26
Calub, C. A., Rapport, M. D., Friedman, L. M., & Eckrich, S. J. (2019) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-019-09728-z · Cited by 30
Howard, A. L., Kennedy, T. M., Macdonald, E. P., Mitchell, J. T., Sibley, M. H., Roy, A., Arnold, L. E., Epstein, J. N., Hinshaw, S. P., Hoza, B., et al. (2019) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-019-00573-y · Cited by 26
Self-citationBrandt, V. C., Patalay, P., & Koerner, J. K. A. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01566-9 · Cited by 27
Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis
Lohr, W. D., Wanta, J. W., Baker, M., Grudnikoff, E., Morgan, W. S., Chhabra, D., & Lee, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.642798 · Cited by 30
Six Stages of Engagement in ADHD Treatment Described by Diverse, Urban Parents
Spencer, A. E., Sikov, J., Loubeau, J. K., Zolli, N., Baul, T. D., Rabin, M. A., Hasan, S., Rosen, K. J., Buonocore, O., Lejeune, J., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2021-051261 · Cited by 29
der Oord, S. V., Prins, P. J. M., Oosterlaan, J., & Emmelkamp, P. M. G. (2011) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.750 · Cited by 24
Vitamin–Mineral Treatment of ADHD in Adults
Rucklidge, J. J., Frampton, C. M., Gorman, B., & Boggis, A. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714530557 · Cited by 24
A Research Model for Investigating the Effects of Artificial Food Colorings on Children With ADHD
Kleinman, R. E., Brown, R. T., Cutter, G., DuPaul, G. J., & Clydesdale, F. M. (2011) · PEDIATRICS · doi:10.1542/peds.2009-2206 · Cited by 24
Specific Ways Brain SPECT Imaging Enhances Clinical Psychiatric Practice
Amen, D., Highum, D., Licata, R. M., Annibali, J. A., Somner, L., Pigott, H. E., Taylor, D. V., Trujillo, M., Newberg, A. B., Henderson, T. A., et al. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.684615 · Cited by 24
Changes in behavior as side effects in methylphenidate treatment: review of the literature
Konrad-Bindl, D. S., Gresser, U., & Richartz, B. M. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114185 · Cited by 24
Mohagheghi, A., Amiri, S., Bonab, N. M., Chalabianloo, G., Noorazar, S. G., Tabatabaei, S. M., & Farhang, S. (2017) · BioMed Research International · doi:10.1155/2017/3513281 · Cited by 24
Riera, M. T., Cervelló, X. C., Tobías, A., Cunill, R., Blanco-Silvente, L., & Capellà, D. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4662-1 · Cited by 27
Differential long-term medication impact on executive function and delay aversion in ADHD
Morell, B. R., & Expósito, S. H. (2017) · Applied Neuropsychology Child · doi:10.1080/21622965.2017.1407653 · Cited by 24
EEG Vigilance and Phenotypes in Neuropsychiatry
Arns, M., Gunkelman, J. D., Olbrich, S., Sander, C., & Hegerl, U. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-382235-2.00004-4 · Cited by 25
Siebelink, N. M., Kaijadoe, S. P. T., van Horssen, F. M., Holtland, J. N. P., Bögels, S. M., Buitelaar, J. K., Speckens, A. E. M., & Greven, C. U. (2020) · Journal of Attention Disorders · doi:10.1177/1087054720945023 · Cited by 24
Rucklidge, J. J., Blampied, N. M., Gorman, B., Gordon, H., & Sole, E. J. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2392 · Cited by 26
Litson, K., Geiser, C., Burns, G. L., & Servera, M. (2016) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2015.1118693 · Cited by 25
Barth, B., Mayer, K., Strehl, U., Fallgatter, A. J., & Ehlis, A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.021 · Cited by 24
See, L., Li, H.-M., Chao, K.-Y., Chung, C.-C., Li, P.-R., & Lin, S.-R. (2021) · Medicine · doi:10.1097/md.0000000000025245 · Cited by 13
Engagement Barriers to Behavior Therapy for Adolescent ADHD
Sibley, M. H., Link, K. M., Antunez, G. T., & Greenwood, L. (2022) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2022.2025597 · Cited by 23
Banaschewski, T., Buitelaar, J. K., Coghill, D., Sergeant, J. A., Sonuga-Barke, E. J. S., Zuddas, A., & Taylor, E. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181bac557 · Cited by 23
Krasner, A., Turner, J. B., Feldman, J. F., Silberman, A. E., Fisher, P. W., Workman, C. C., Posner, J. E., Greenhill, L. L., Lorenz, J. M., Shaffer, D., et al. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715617532 · Cited by 25
Self-citationMutations in sphingolipid metabolism genes are associated with ADHD
Henríquez‐Henríquez, M., Acosta, M. T., Martinez, A. F., Velez, J. I., Lopera, F. J., Pineda, D. A., Palacio, J. D., Quiroga, T., Worgall, T. S., Deckelbaum, R. J., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00881-8 · Cited by 26
Self-citationMiranda, A., Diago, C. C., Andrés, M. I. F., Herrero, M. J. P., & Miranda, B. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128325 · Cited by 28
DuPaul, G. J., Kern, L., Gormley, M. J., & Volpe, R. J. (2011) · School Mental Health · doi:10.1007/s12310-011-9053-x · Cited by 22
Owens, J. (2020) · Sociology of Education · doi:10.1177/0038040720909296 · Cited by 22
Meyer, J., Öster, C., Ramklint, M., & Isaksson, J. (2020) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12655 · Cited by 22
Dekkers, T., Huizenga, H., Bult, J., Popma, A., & Boyer, B. (2020) · European Child and Adolescent Psychiatry · doi:10.1007/s00787-020-01579-4 · Cited by 18
Social Class, Diagnoses of Attention-Deficit/Hyperactivity Disorder, and Child Well-Being
Owens, J. (2020) · Journal of Health and Social Behavior · doi:10.1177/0022146520924810 · Cited by 22
Herrero, M. J. P., Hierro, R. S., Jiménez, P. J., & Casas, A. M. (2010) · PubMed · Cited by 22
Slattery, L., Crosland, K. A., & Iovannone, R. (2015) · Journal of Positive Behavior Interventions · doi:10.1177/1098300715588282 · Cited by 22
Pharmacotherapy for Parents with Attention-Deficit Hyperactivity Disorder (ADHD)
Chronis-Tuscano, A. M., & Stein, M. A. (2012) · CNS Drugs · doi:10.2165/11633910-000000000-00000 · Cited by 24
ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN, ADOLESCENTS, AND ADULTS
Schachar, R. J. (2009) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000348879.09070.21 · Cited by 22
Boesen, K., Saiz, L. C., Erviti, J., Storebø, O. J., Gluud, C. N., Gøtzsche, P. C., & Jørgensen, K. J. (2017) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2017-110716 · Cited by 22
Writing abilities longitudinally predict academic outcomes of adolescents with ADHD.
Molitor, S. J., Langberg, J. M., Bourchtein, E., Eddy, L. D., Dvorsky, M. R., & Evans, S. W. (2016) · School Psychology Quarterly · doi:10.1037/spq0000143 · Cited by 25
Pelham, W. E., & Altszuler, A. R. (2020) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000777 · Cited by 21
Associated predictors of functional impairment among adolescents with ADHD—a cross-sectional study
Meyer, J., Alaie, I., Ramklint, M., & Isaksson, J. (2022) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-022-00463-0 · Cited by 26
Identifying Common and Unique Elements of Evidence-Based Treatments for Adolescent ADHD
Rios-Davis, A., Sibley, M. H., Delgado, A., & Zulauf-McCurdy, C. A. (2022) · Journal of Child and Family Studies · doi:10.1007/s10826-022-02475-y · Cited by 21
Effect of Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder on Criminality
Widding‐Havneraas, T., Zachrisson, H. D., Markussen, S., Elwert, F., Lyhmann, I., Chaulagain, A., Bjelland, I., Halmøy, A., Rypdal, K., & Mykletun, A. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2023.05.025 · Cited by 24
Flory, K., Malone, P. S., & Lamis, D. A. (2011) · Psychology of Addictive Behaviors · doi:10.1037/a0022633 · Cited by 24
Rucklidge, J. J., & Kaplan, B. J. (2014) · CNS Drugs · doi:10.1007/s40263-014-0190-2 · Cited by 21
Zendarski, N. J., Sciberras, E., Mensah, F. K., & Hiscock, H. (2016) · BMC Pediatrics · doi:10.1186/s12887-016-0555-4 · Cited by 21
Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacology
Grabb, M. C., & Gobburu, J. V. S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.003 · Cited by 21
Reed, M. O., Jakubovski, E., Johnson, J. A., & Bloch, M. H. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0168 · Cited by 21
Stimulants and Pediatric Cardiovascular Risk
ZITO, J. M., & Burcu, M. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0239 · Cited by 21
Rasmussen, P. D., Bilenberg, N., Shmueli‐Goetz, Y., Simonsen, E. H., Bojesen, A. B., & Storebø, O. J. (2019) · Journal of Child and Family Studies · doi:10.1007/s10826-019-01344-5 · Cited by 21
Special Education and the New Mental Health: A Response to New Direction of CCBD?
Forness, S. R. (2011) · Behavioral Disorders · doi:10.1177/019874291103700105 · Cited by 21
Exploring five common assumptions on Attention Deficit Hyperactivity Disorder
Batstra, L., Nieweg, E. H., & Hadders-Algra, M. (2014) · Acta paediatrica · doi:10.1111/apa.12642 · Cited by 26
Diversion of ADHD Stimulants and Victimization Among Adolescents
Epstein-Ngo, Q. M., McCabe, S. E., Veliz, P. T., Stoddard, S. A., Austic, E. A., & Boyd, C. J. (2015) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsv105 · Cited by 21
Efficacy of online intervention for ADHD: a meta-analysis and systematic review
Shou, S., Xiu, S., Li, Y., Zhang, N., Yu, J., Ding, J., & Wang, J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.854810 · Cited by 20
Mindfulness as an Adjunct to Behavior Modification for Elementary-aged Children with ADHD
Ramos, M. C., Macphee, F. L., Merrill, B. M., Altszuler, A. R., Raiker, J. S., Gnagy, E. M., Greiner, A. R., Parent, J. M., Coles, E. K., Burger, L., et al. (2022) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-022-00947-9 · Cited by 21
Schein, J. R., Childress, A. C., Adams, J., Gagnon‐Sanschagrin, P., Maitland, J., Qu, W., Cloutier, M., & Guérin, A. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04188-4 · Cited by 24
Yang, G., Liu, Q., Wang, W., Liu, W., & Li, J. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1376354 · Cited by 28
Kim, J.-W., Yu, H., Ryan, N. D., Axelson, D., Goldstein, B. I., Goldstein, T. R., Diler, R. S., Monk, K., Hickey, M. B., Sakolsky, D. J., et al. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09095 · Cited by 20
Shooting the Messenger: The Case of ADHD
Watson, G. L., Arcona, A. P., Antonuccio, D. O., & Healy, D. (2013) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-013-9244-x · Cited by 20
Metadata
- Authors
- Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., Elliott, G. R., Greenhill, L. L., Newcorn, J. H., Wells, K. C., Wigal, T., Gibbons, R. D., Hur, K., & Houck, P. R.
- Affiliations
- University of Pittsburgh (US)
- University of California, Berkeley (US)
- University of California, Irvine (US)
- National Institute of Mental Health (US)
- Duke University (US)
- Long Island Jewish Medical Center (US)
- New York State Psychiatric Institute (US)
- University of Illinois Chicago (US)
- Corresponding author
- Molina, Brooke S.G.
- ORCID
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 48
- Issue
- 5
- Pages
- 484-500
- ISSN
- 0890-8567 (ISSN-L)
- PMC
- PMC3063150
- OpenAlex
- W2144385879
- Cited by
- 1,182
- References
- 55
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 37 · 2023: 39 · 2022: 53 · 2021: 44 · 2020: 69 · 2019: 79 · 2018: 59 · 2017: 85 · 2016: 108 · 2015: 92 · 2014: 109 · 2013: 76 · 2012: 94
- FWCI
- 53.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- U.S. Department of Justice
- U.S. Department of Education
- Abbott Laboratories
- Eli Lilly and Company
- Pfizer
- Sanofi
- Purdue University
- Celgene
- University of Pittsburgh (HHSN271200800008-C, U01 MH50467, N01MH 12010)
- McGill University (N01MH12008, HHSN271200800003-C)
- Purdue Pharma
- York University
- National Institutes of Health (n01mh12011-0-0-1, n01mh012009-007, n01mh12008-0-0-1, n01mh12010-0-0-1, n01mh12004-0-0-0, n01mh12007-0-0-0, n01mh012012-001)
- Medical Center, University of Pittsburgh
- University of California, Irvine (HHSN271200800006-C, N01MH 12004)
- National Institute of Mental Health (U01MH50461, N01 MH12007, N01MH-12012, N01 MH012007, U01MH50440, N01MH12008,, U01MH050467, MH-50467, N01 MH012009, U01 MH50477, N01 MH012011, U01MH050447, U01MH050440, N01 MH012012, N01 MH12009, U01MH050453, N01 MH012010, U01MH50467, U01MH050461, N01MH 12004, U01MH50453, N01MH 12010, U01MH050454, N01 MH012004, N01 MH012008)
- National Institute on Drug Abuse (HHSN271200800003C, HHSN271200800006C, N01 DA085550, N01 DA085552, HHSN271200800008C, N01 DA085549, HHSN271200800005C, N01 DA085551, N01 DA085548, HHSN271200800007C, HHSN271200800009C, N01 DA085553, N01 DA085554, R01DA012414, HHSN271200800004C)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, combined type ADHD, long-term outcomes, symptom trajectories, prognostic factors, treatment effects, medication use, adolescent functioning, academic performance, arrests, psychiatric hospitalization
- MeSH terms
- Adolescent, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Behavioral Symptoms, Child, Combined Modality Therapy, Community Mental Health Services, Female, Follow-Up Studies, Humans, Male, Psychiatric Status Rating Scales, Psychotropic Drugs, Reference Values, Regression Analysis, Case-Control Studies, Treatment Outcome, Attention Deficit and Disruptive Behavior Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
